Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Res Autism Spectr Disord. 2019 Jun 15;66:101410. doi: 10.1016/j.rasd.2019.101410

Community-based service use in preschool children with autism spectrum disorder and associations with insurance status

Eric Rubenstein a, Lisa Croen b, Li-Ching Lee c, Eric Moody d, Laura A Schieve e, Gnakub N Soke e, Kathleen Thomas f, Lisa Wiggins e, Julie Daniels g
PMCID: PMC7430759  NIHMSID: NIHMS1532073  PMID: 32831903

Abstract

Background:

ASD-related services can improve outcomes for children, but less is known about service outside of school settings during preschool age. We aimed to describe amount and category of community-based service use among 3-5-year-old children with ASD and examine differences by health insurance.

Methods:

We used cross-sectional data on 792 children with ASD diagnoses in the Study to Explore Early Development, a community-based study of neurodevelopment with enrollment between 2012-2016. Mothers reported current child service use and insurance status at study entry. We used log-Poisson and logistic regression to compare service use by insurance group.

Results:

Nearly 40% of children were not receiving community-based services at study entry. Children with public insurance had fewer total services than children with private or both insurances. After adjustment for sociodemographic confounders, insurance status was not associated with types of different categories of community-based services. However, children with public insurance alone were least likely to receive community-based behavioral therapy and most likely to receive psychotropic medication compared to other insurances.

Conclusion:

Many preschool-aged children do not receive community-based services, with receipt associated with insurance type. Increasing access and availability for evidence-based service, especially for beneficiaries of public insurance, may improve service use and outcomes.

Keywords: Autism spectrum disorder, service, therapy, insurance, behavioral therapy

Introduction

The most recent Autism and Developmental Disabilities Monitoring Network estimate of ASD prevalence in 8-year-old children in sites across the US is 1 in 59, with median age of diagnosis at 52 months (Baio et al., 2018). With increasing identification of ASD at younger ages (Baio et al., 2018) it is crucial that appropriate medical and behavioral-based services, treatments, and therapies (hereafter referred to collectively as ‘services’) are available and accessible (Dawson & Burner, 2011; Zablotsky et al., 2015). Such early identification and referral to services have been shown to improve outcomes and reduce expenditures for families and health systems (Horlin, Falkmer, Parsons, Albrecht, & Falkmer, 2014; Leigh, Grosse, Cassady, Melnikow, & Hertz-Picciotto, 2016). A particularly crucial time for intervention is period before the age of 5 years where a child develops many social and communication skills (Koegel, Koegel, Ashbaugh, & Bradshaw, 2014; Zwaigenbaum et al., 2015). Providing adequate and timely services to preschool children with ASD has been shown to have positive impacts on both short and long-term outcomes (Koegel et al., 2014).

Most services for children with ASD aim to improve adaptive functioning, language, social skills, as well as reduce challenging behaviors (Harrington & Allen, 2014). Behavioral therapy is a common intervention for children with ASD and is based on identifying the antecedents and consequences of specific behaviors to modify environmental conditions according to the needs of the child (Kasari, 2015). Behavioral therapy, which includes Applied Behavior Analysis, is considered among “best practice” guidelines for treating ASD symptoms in young children. However, behavioral therapy covers a range of approaches with uncertainty about optimal designs, intensity, and approach (Reichow, Hume, Barton, & Boyd, 2018; Zwaigenbaum et al., 2015). Speech therapy is a common service for children with ASD, especially in school settings (O’Hare & Bremner, 2016), as language delays are among the first symptoms noted by parents of children with ASD (Herlihy, Knoch, Vibert, & Fein, 2015). Physical therapy (PT) and occupational therapy (OT) are used to address common physical and adaptive challenges associated with ASD, as well as sensory over- or under-response (Hebert, Kehayia, Prelock, Wood-Dauphinee, & Snider, 2014; Semansky, Xie, Lawer, & Mandell, 2013). Social skills training focuses on social deficits and can include peer-mediated interventions or stories that provide visual cues to help navigate unfamiliar social interactions (Bohlander, Orlich, & Varley, 2012). Medications are often prescribed to treat certain symptoms associated with the ASD phenotype, such as inattention, and hyperactivity (Baribeau & Anagnostou, 2014). In addition to standard care, caregivers commonly initiate complementary health approaches (CHA) for their children with ASD in an attempt to alleviate symptoms (Barrett et al., 2015; Levy & Hyman, 2015; Rubenstein et al., 2018). While we present services by type, it is important to note that there are myriad of variants in approach, intensity, duration, and setting for each type of service (Lord, Elsabbagh, Baird, & Veenstra-Vanderweele, 2018).

Research finds that children with ASD often do not get the level of services that families desire. In the 2009-2010 National Survey of Children with Special Health Care Needs of children <18 with ASD, 24.4% had unmet service needs (Benevides, Carretta, Ivey, & Lane, 2017). In that same study, caregivers reported the most common reason for difficulty in obtaining services were cost, health plan problems, and lack of school resources (Benevides et al., 2017). Using data from the 2011-2014 National Health Interview Study, Lindly et al. (2018) found that 15.8% of children 2-17 with ASD had a delay accessing needed care and 14.5% could not afford any needed care. During preschool age, many children receive services but behavioral based therapies are less common (Payakachat, Tilford, & Kuhlthau, 2018). Appropriate services, especially during the early childhood period, are crucial to improve short and long-term outcomes (Koegel et al., 2014). Better our understanding of determinants and associated factors for why these gaps in care exist will enable for better service allocation and care for preschool-age children with ASD.

The unmet service need is partially attributable to a lack of access to community-based care (Lindly et al., 2018). Children who meet criteria for special education services are required by law to receive individualized services for ASD (“Individuals with Disabilities Education Improvement Act of 2004,” 2004); however, care is often needed outside the school setting. Often, community-based services take place at specialty clinicians or programs like Head Start and have a cost-whether out-of-pocket or to the government or insurance providers (Candon et al., 2018). In the context of health insurance, a child may receive public coverage because a family meets certain income requirements or through a special waiver program. A child may be enrolled in private insurance because a family buys into a plan or a parent’s employer provides coverage (Lindly et al., 2018). Insurance status is an important indicator for socioeconomic status and may highlight disparity in health care utilization (Lindly et al., 2018). Over the last ten years, many states have enacted insurance mandated laws impacting how private insurance providers cover children with ASD (Barry et al., 2017; Douglas, Benevides, & Carretta, 2017). Governmental programs like the Children’s Health Insurance Program (CHIP) and Medicaid are required to provider certain ASD-related coverage and are available to the public if they meet certain eligibilities (Barry et al., 2017; Douglas et al., 2017). In addition to public and private programs, state-based Medicaid Home and Community Based Services (HCBS) waivers provide services to eligible children with ASD or developmental disabilities regardless of family income (Cidav, Marcus, & Mandell, 2014; Leslie et al., 2017; Vohra, Madhavan, & Sambamoorthi, 2017; Wang, Mandell, Lawer, Cidav, & Leslie, 2013). States differ in how children are eligible for the waivers, how many receive the waiver, and what services they cover (Velott et al., 2016). Waiver programs allow public insurance money to supplement existing public or private insurance for ASD-related expenditures.

Although insurance programs and laws have aimed to expand care for children with ASD, many programs and service providers are burdened with long waitlists and limited funds and many children do not get the services they need (Miller, Merryman, Eskow, & Chasson, 2016). Insurance type likely impacts access; one study found that children with ASD enrolled in Medicaid were more likely to have visits to OTs, PTs, and behavioral therapists compared to children on private insurance (Wang et al., 2013). Children with ASD-related HCBS waivers were more likely to have outpatient visits and less likely to have inpatient visits and long-term treatment than children without HCBS waivers (Cidav et al., 2014). The community-based service a child receives is affected by the insurance policies in place at a state (i.e. HCBS waivers, insurance mandates) and state and national level (i.e. Medicaid, CHIP) as well as an individual family’s ability to spend out-of-pocket and familiarity with service systems (Candon et al., 2018; Miller et al., 2016; Thomas, Parish, & Williams, 2014).

Appropriate services for preschool children with ASD are crucial for development; yet, there may be differences in service use due to socioeconomic factors. The objective of the present study was to describe community-based service use at a critical developmental age (3-5 years) among children with a diagnosis of ASD using data from the Study to Explore Early Development (SEED). Additionally, we examined differences by insurance status (public insurance, private insurance, or combined insurance [i.e. private insurance and HCBS waiver]). Lastly, we evaluated whether the association between insurance status and service use differed by the child’s ASD symptom severity. We hypothesized that we would see a proportion of preschool age children who did not receive community-based service and that proportion would be associated with insurance type.

Methods

Design and participant ascertainment

We used data from SEED; a community-based multi-site case-control study of ASD etiology and phenotype in children 30-68 months old (Schendel et al., 2012). Six sites participated in the study (California, Colorado, Georgia, Maryland, North Carolina and Pennsylvania). We used data from families who completed the study between 2012 and 2016. Each site’s institutional review board and the review board at the Centers for Disease Control and Prevention approved the SEED protocol. Additional SEED information can be found in Schendel et al. (2012).

Three groups of children and their mothers were invited to participate in this study: children with ASD, children with other (non-ASD) developmental disabilities and children from the general population. Children were identified from healthcare providers and education agencies that diagnosed or served children with disabilities and from random sampling of birth certificates in each study site’s catchment area (selected counties in a state with >35,000 live births per year). This present study was concerned with services used by children with ASD, thus we limited our analysis to children with ASD diagnosis prior to study enrollment. SEED methodology was designed to identify children with no past diagnosis of ASD, but those children would not have had opportunity for ASD-related service. Past diagnosis was ascertained by asking the mother about her child’s diagnostic history and/or by reviewing diagnostic codes. We excluded 12.7% of children who met SEED criteria for ASD case status but did not have an ASD diagnosis prior to enrollment, thus would not have been eligible for ASD-related services prior to study entry (Wiggins et al., 2015). A group of children with prior ASD diagnosis did not meet SEED ASD criteria during the research evaluation; because these children had a prior ASD diagnosis and could have received services we included them in this analysis.

Current service

As part of SEED data collection, the mother completed a questionnaire developed by SEED investigators aimed at capturing information on ASD-related service use. Mothers filled out a questionnaire that asked ‘Has your child ever used any of the following services or therapies’ followed by a list of potential services. For each service reported, the mother was asked whether the child was still receiving this service and whether the service took place out-of-school. We examined services that were explicitly prompted: speech therapy, OT, behavior therapy, respite care, social skills training, PT, CHA, and ‘other’ (see supplement 1a). Specific CHA therapies that required seeing a service provider (chelation therapy, chiropractic care, hyperbaric oxygen therapy, and immune treatments) were analyzed as a group. We ascertained medication use from the answer to the following question: ‘Is your child currently on any prescription medications for ASD-related symptoms or behaviors, including antidepressants/antianxiety or anti-obsessive-compulsive medications, atypical antipsychotics, medications to treat seizures or stabilize mood, and non-stimulants used to treat hyperactivity?’

Insurance status

SEED collected data on child insurance status through a child health history form completed by the mother. The form included the question ‘Does your child currently have any of the following types of health insurance coverage: 1) Private insurance including HMOs (provided through a job or private insurance); 2) Government plans (e.g. Medicaid); 3) Other type of insurance (and if yes, specify); 4) Child is currently uninsured.’ Respondents could indicate more than one type of insurance coverage. The text field for the ‘other’ group was assessed to determine whether any listed responses would fit in the private or public category (See supplement 1b). We coded insurance status into 4 categories for analysis: 1) private insurance alone, 2) public insurance alone, 3) combined insurance (both private and public insurance), 4) uninsured. Participants were not asked about the specific plan in which the child was currently enrolled or prior history of health insurance enrollment. We did not include uninsured children in our analyses due to small sample size (N=11, 1.4%).

Other covariates

The Social Communication Questionnaire (Rutter, Bailey, & Lord, 2003) was administered as a preliminary screener for the study and we dichotomized whether the child met criteria (cutoff score ≤11 to improve identification in children under 4; (Wiggins, Bakeman, Adamson, & Robins, 2007)). We used demographic data from the SEED maternal interview to examine characteristics of the sample. Mothers were asked their education (categorized as <High school degree, high school degree, some college, >=bachelor’s degree), race (white, black, Asian, other), and family income in the past 12 months (<$30,000, $30,000-$90,000, >$90,000). Mothers were also asked how many children were living in the household at the time of the interview and we categorized that into 1, 2, or 3+ children. ASD severity was derived from the Autism Diagnostic Observation Schedule (Lord et al., 2000), which children with past ASD diagnoses were administered as part of the SEED study protocol.

Analysis

We created binary indicators for each current service use (speech therapy, OT, behavior therapy, social skills training, respite care, PT, medication, CHA, and other). The cumulative types of different categories of service reflects the sum of these indicator variables. To evaluate associations between types of different categories of service and insurance status, we used log Poisson regression with study site as a random intercept. In our data, the mean amount of service types a child received was not statistically significantly different than the variance, supporting the use of a Poisson model. Having site as a random intercept allowed us to account for differences at the state level and variance between data collection across sites. In the adjusted models we controlled for confounders identified a priori based on a directed acyclic graph: maternal education, race, family income, number of children in the household, and child’s year of birth. We selected these variables because of the association between socioeconomic status and insurance and ASD related disparity. Additionally, including child’s year of birth allowed us to account for child age and trend effects. As a sensitivity analysis, we evaluated differences when additionally incorporating school-based services, as identified using the same methodology used for community-based services. To examine the association between use of a specific service and insurance status, we ran logistic regression models for each service, controlling for previously mentioned covariates. We assessed whether the associations between insurance status and total types of services used, behavioral therapy, and medication use differed by ASD severity. Because of small sample size in the stratified model we re-parameterized race (white or not white) and education (no college, some or more college) to improve model convergence. Statistical significance is presented at an alpha=0.05 level.

Results

Demographic characteristics

Our analytic sample consisted of 792 children with an ASD diagnosis prior to study enrollment (Table 1). At the time of data collection, 279 children (34.7%) were covered by public insurance alone, 406 (50.6%) had private insurance alone, and 107 (13.3%) had combined insurance. Less than half of mothers with children enrolled in public insurance alone were white whereas two-thirds of mothers with children on private insurance alone and three-quarters with combined insurance were white. More than half of the mothers with children on public insurance alone reported an income in the last 12 months <$30,000 and of those with private insurance alone, approximately half earned ≥$90,000.

Table 1.

Demographic characteristics of children with previous diagnosis of autism spectrum disorder in the Study to Explore Early Development, by insurance status

All
N=792
Public insurance alone
N=279
Private insurance alone
N=406
Combined insurance
N=107
N % N % N % N %
Maternal race
 White 465 58.8 115 41.2 270 66.5 80 74.8
 Black 216 27.3 138 49.5 61 15.0 17 15.9
 Asian 63 8.0 7 2.5 51 12.6 5 4.7
 Other 47 5.9 18 6.5 24 5.9 5 4.7
 Missing 1 1
Hispanic ethnicity
 Hispanic 109 14.0 54 19.7 40 10.1 15 14.0
 Non-Hispanic 669 86.0 220 80.3 357 89.9 92 86.0
 Missing 14 5 9
Maternal education
 <High school degree 31 3.9 25 9.0 4 1.0 2 1.9
 High school degree 77 9.8 52 18.8 15 3.7 10 9.3
 Some college 259 32.8 131 47.3 104 25.7 24 22.4
 ≥Bachelor’s degree 423 53.6 70 25.3 282 69.6 71 66.4
 Missing 2 1 1
Child sex
 Male 639 80.7 230 82.4 325 80.0 84 78.5
 Female 153 19.3 49 17.6 81 20.0 23 21.5
Child year of birth
 2008 245 30.9 87 31.2 124 30.5 34 31.8
 2009 216 27.3 75 26.9 115 28.3 26 24.3
 2010 206 26.0 69 24.7 105 25.9 32 29.9
 2011 125 15.8 48 17.2 62 15.3 15 14.0
Year of study completion
 2010 1 0.1 1 0.4 0 0.0 0 0.0
 2012 110 13.9 32 11.5 63 15.5 15 14.0
 2013 222 28.0 78 28.0 116 28.6 28 26.2
 2014 181 22.9 61 21.9 102 25.1 18 16.8
 2015 256 32.3 99 35.5 115 28.3 42 39.3
 2016 22 2.8 8 2.9 10 2.5 4 3.7
Final Classification
 ASD 666 84.1 227 81.4 345 85.0 94 87.9
 DD 126 15.9 52 18.6 61 15.0 13 12.1
ADOS Severity Score
 <7 332 42.0 126 45.2 157 38.9 49 45.8
 >=7 458 58.0 153 54.8 247 61.1 58 54.2
 Missing 2 2
Child age at clinic visit (months)
 Median, IQR 57.0 12.9 57.5 13.5 56.2 12.9 58.6 11.3
Social Communication Questionnaire score
 Median, IQR 17.0 9.5 18.0 8.0 15.0 9.0 18.0 10.0
Site
 California 134 16.9 24 8.6 99 24.4 11 10.3
 Colorado 116 14.6 46 16.5 59 14.5 11 10.3
 Georgia 174 22.0 84 30.1 69 17.0 21 19.6
 Maryland 140 17.7 43 15.4 89 21.9 8 7.5
 North Carolina 120 15.2 39 14.0 71 17.5 10 9.3
 Pennsylvania 108 13.6 43 15.4 19 4.7 46 43.0
Income in past 12 months
 <$30,000 197 24.9 167 61.4 16 4.0 14 13.5
 $30,000-$90,000 325 41.0 103 37.9 175 44.2 47 45.2
 >$90,000 252 31.8 4 1.5 205 51.8 43 41.3
 Missing 18 2.3 5 10 3
Children living in the household
 1 212 26.8 80 28.7 106 26.2 26 24.3
 2 374 47.3 96 34.4 225 55.7 53 49.5
 3+ 204 25.8 103 36.9 73 18.1 28 26.2
 Missing 2 2

ADOS: Autism Diagnostic Observation Schedule, higher score indicates more severe presentation

IQR: Inter quartile range

ASD: Autism spectrum disorder

DD: Developmental disability

N=11 were uninsured at time of enrollment

Services used

Approximately 60% of children received ≥1 community-based service (Table 2). Speech therapy and OT were the most common services for the overall sample and in each insurance group. Slightly less than half of children on public insurance alone received no community-based services (47.0%) compared with 33.7% of privately insured and 36.4% of children with combined insurance

Table 2.

Cumulative total and categories of community-based services used by children with a previous diagnosis of ASD at enrollment into the Study to Explore Early Development, by insurance status

All
N=792
Public insurance alone
N=279
Private insurance alone
N=406
Combined insurance
N=107
N % N % N % N %
Amount of service types used
 0 307 38.8 131 47.0 137 33.7 39 36.4
 1 207 26.1 66 23.7 121 29.8 20 18.7
 2 148 18.7 44 15.8 82 20.2 22 20.6
 3 95 12.0 30 10.8 45 11.1 20 18.7
 4 24 3.0 8 2.9 13 3.2 3 2.8
 5 9 1.1 0 0.0 7 1.7 2 1.9
 6 2 0.3 0 0.0 1 0.2 1 0.9
Specific service
 Speech therapy 289 36.5 94 33.7 155 38.2 40 37.4
 Occupational therapy 230 29.0 76 27.2 117 28.8 37 34.6
 Behavior therapy 161 20.3 24 8.6 112 27.6 25 23.4
 Medication 82 10.4 33 11.8 39 9.6 10 9.3
 Social Skills training 51 6.4 15 5.4 27 6.7 9 8.4
 Respite care 48 6.1 11 3.9 29 7.1 8 7.5
 Physical therapy 33 4.2 11 3.9 14 3.4 8 7.5
 CHA 14 1.8 5 1.8 6 1.5 3 2.8
 Other 31 3.9 6 2.2 13 3.2 12 11.2

CHA: Complementary health approaches

CHA includes chelation, chiropractic, immune treatments, and hyperbaric oxygen therapies

Medication includes: anti-depressants, atypical antipsychotics, seizures or mood stabilizers, non-stimulants for hyperactivity, stimulant medications for hyperactivity

Children without insurance were not included due to small sample size

Other services are listed in supplement 1b.

Cumulative categories of service use

Mean types of service currently used in the public insurance alone group was 0.99 (standard deviation [SD]:1.1), 1.26 in the private insurance alone group (SD: 1.2), and 1.42 in the combined insurance group (SD: 1.4). In unadjusted log-Poisson models estimating prevalence ratios (PR), children with either private insurance alone or combined insurance used a greater amount of types of community-based services compared to children with public insurance alone (Table 3). However, after adjustment for confounding, children with private insurance alone had 0.83 times the categories of service use compared to children with public insurance alone, but this result was not statistically significant with the confidence interval including the null (95% CI 0.67, 1.03).

Table 3.

Associations between community-based service use and insurance status in children with previous diagnosis of autism spectrum disorder at time of enrollment in the Study to Explore Early Development

Unadjusted Adjusted
OR 95% CI OR 95% CI
Amount of service types used*
Public REF REF
Private 1.18 1.02 1.38 0.83 0.67 1.03
Both 1.61 1.32 1.98 1.17 0.92 1.49
Speech therapy
Public REF REF
Private 1.18 0.84 1.64 0.93 0.58 1.51
Both 1.45 0.89 2.36 1.19 0.67 2.12
Occupational therapy
Public REF REF
Private 1.10 0.63 1.29 0.66 0.39 1.13
Both 1.85 1.76 1.95 1.24 0.68 2.29
Behavioral therapy
Public REF REF
Private 2.96 1.80 4.87 1.81 0.85 3.85
Both 4.23 2.15 8.30 2.34 1.02 5.35
Medication
Public REF REF
Private 0.78 0.47 1.30 0.32 0.14 0.71
Both 0.84 0.39 1.83 0.49 0.19 1.27
Social skills training
Public REF REF
Private 1.25 0.65 2.40 0.70 0.28 1.71
Both 1.62 0.69 3.81 0.97 0.35 2.68
Respite care
Public REF REF
Private 0.90 1.94 0.42 0.90 0.30 2.71
Both 2.46 0.87 6.97 2.41 0.72 8.07
Physical therapy
Public REF REF
Private 0.94 0.42 2.13 0.49 0.16 1.54
Both 2.13 0.82 5.55 0.99 0.29 3.38

OR: odds ratio

REF: reference group

CI: confidence interval

*

Amount of service types used used log-Poisson regression to estimate prevalence ratios, all other estimates are odds ratios derived from logistic regression

Adjusted models controlled for income, number of children in home, maternal education, race, and ethnicity, child year of birth and site as a random intercept.

Medication includes: anti-depressants, atypical antipsychotics, seizures or mood stabilizers, non-stimulants for hyperactivity, stimulant medications for hyperactivity

Other and CHA did not have adequate sample size to assess

Bold indicates statistical significance at an alpha=0.05 level

N=32 (4%) observations dropped due to missing covariate data

Odds ratios for services

When we examined the use of specific services by insurance status (Table 3), we found increased unadjusted-odds of receiving community-based behavioral therapy in children on private insurance only or combined insurance compared to children on public insurance. After adjusting for confounders our results were attenuated when comparing children with private insurance only (adjusted Odds Ratio (aOR): 1.81; 95% CI 0.85, 3.85) and combined insurance (aOR: 2.34; 95% CI: 1.02, 5.35) to public insurance alone. We found a negative association between being on private insurance and psychotropic medication prescription, with children on private insurance alone having 0.32 times the adjusted odds of having a prescription compared to children on public insurance alone (95% CI: 0.14,0.71). In our sensitivity analysis incorporating school-based services, our estimates did not meaningfully change (Supplement 2). We note that 95 children received no in- or out- of school services (12.0%) and 212 (26.7%) received in-school service only.

Impact of severity

The cumulative amount of service types used was greater for those with higher ASD symptom severity (mean service types used:.36, SD: 1.3) compared to those with lower ASD symptom severity (mean: 0.94, SD 1.1). There was no association between amount of service types used and insurance status within strata of severity. Among children with more severe ASD, the odds of community-based behavioral therapy were higher among those with private insurance alone compared to children with public insurance alone (aOR 3.06, 95% CI 1.23, 7.59). Among the lower severity group, children with combined insurance had higher odds of community-based behavioral therapy compared to children with public insurance alone (aOR 4.88, 95% CI 1.23, 19.33).

Discussion

Relatively little descriptive epidemiological work has assessed patterns in community-based service use for preschool age children with ASD. Understanding these patterns is important given that services received in the preschool years are associated with improved development outcomes later in life (Koegel et al., 2014; Landa & Kalb, 2012). In a sample of 3-5-year-old children between 2012 and 2016 with previously diagnosed ASD, 40% were not receiving community-based services and one-quarter received only one community-based service at time of study entry. We found distinct differences based on insurance status, which may illustrate a disparity in service access.

In terms of amount and categories of service use, our results were similar to findings reported for preschool children with ASD, with speech therapy and OT being most common services (Stahmer, Suhrheinrich, & Mandell, 2016). In data with similar methodology in California, Akins et al.(2014) also found highest use of speech therapy (91.4%) and OT(71.6%) in a sample of preschool age children with ASD but estimates were higher than we saw in our sample. Differences may be because our study assessed a wide sample of children who ever had an ASD diagnosis, a target sample not limited to children with clinically confirmed ASD diagnosis. Alternatively, the California sample may have a different pattern of insurance enrollment compared to our sample. In other studies, using different sampling methods, results were in line with our findings; Mire et al. (2015) assessed data from the Simons Simplex Collection and found approximately 30% of children 3-5 with ASD had private speech therapy and approximately 20% had private OT. Payakachat et al. (2018) looked at service use in preschoolers registered in the Autism Speaks Treatment Network and found speech therapy was most widely used followed by OT, and only 28% of children had behavioral therapy.

In assessing how service patterns differ by insurance status, we did not see statistically significant differences between amount of types of community-based service received between public and private insurance. Although this result did not meet statistical significance, the negative association of the adjusted effect estimate is in line with previous studies (Wang et al., 2013; Zhang & Baranek, 2016). We may see less service use in children enrolled in private insurance alone because the private insurers were more prohibitive in covering ASD services, meaning a family has to pay more out of pocket (Wang et al., 2013). While state level insurance mandates requiring private insurers to cover ASD-related services have been enacted, the resulting effects in service coverage has been gradual (Barry et al., 2017). Another hypothesis is that the children in most need of service with private insurance may be more likely to be dual enrolled in Medicaid through programs like Katie Beckett waivers (state waivers that cover children who need an institutional level of care without the income requirements of Medicaid) or HCBS waivers (Miller et al., 2016).

The movement of our estimates towards the null after adjustment for variables like maternal education, race, and income is consistent with the disparity due to race and other socioeconomic characteristics seen when assessing any service use for children with ASD (Broder-Fingert, Shui, Pulcini, Kurowski, & Perrin, 2013; Locke et al., 2017; Payakachat et al., 2018). The effect of socioeconomic status and demographic characteristics on the association between insurance status and service use may indicate that insurance status (among those insured) is not the primary driver of differences in service use (Chou, Tulolo, Raver, Hsu, & Young, 2013). The impact of other non-insurance sociodemographic characteristics may be especially important since we could not determine which therapies or services were covered by insurance providers and which were paid for out-of-pocket. Such unmeasured variables could include knowledge of the health care system and distance to service providers. Out-of-pocket expenses are more likely among families of children with private insurance alone, likely due to the increased income that may allow a family to pay additional service-expenses (Zhang & Baranek, 2016). More work is needed to assess whether there are multiplicative effects between insurance status and disparity of service use (i.e. children in a racial minority group and on Medicaid receive fewer services than white children on Medicaid), which might clarify what populations to target to even the service gap. To build on this work, we aim to further explore the impact of the medical home, or a team health care delivery model, on how these children receive services.

There were stark differences in receipt of behavioral therapy by insurance status; children with public insurance alone were least likely to receive community-based behavioral therapy. Our finding is in contrast to Wang et al (2013), who found more behavioral therapy visits among children enrolled in Medicaid, although they assessed 2003 Medicaid claims of children ≤17 years old. It is important that all young children with ASD have access, both in availability and affordability, to appropriate behavioral therapies so they have opportunities to advance skill development and maximize future potential. While our study did not assess the individual family’s reason for not using behavioral therapy or the quality of therapy received, a potential explanation for the gap we saw is a lack of access for children of low socioeconomic status, as indicated by public insurance status. In our sample, children on public insurance alone were less likely to receive behavioral therapy, these children were more likely to be prescribed medications. Similar to our findings on behavioral therapy, we cannot be certain whether the medication allocated was appropriate or whether it was fully driven by socioeconomic differences. However, our finding was consistent with past literature (Houghton, Ong, & Bolognani, 2017; Jackel et al., 2017). A hypothesis for the difference in prescribing practice we see in our study and in the literature is that differences may be a result of suboptimal prescribing practice; or , the lack of access to and knowledge about behavioral therapies for a child of lower socioeconomic status leads to greater reliance on psychotropic medication (Houghton et al., 2017; Jackel et al., 2017). Improving availability and insurance coverage for other services, like behavioral therapy, may be one way to reduce the reliance on potentially unnecessary medication. Further approaches may also alter prescribing practice, including continued work in creating and adapting implementable community-based behaviorally based ASD interventions (Vivanti et al., 2018), and promoting provider education about ASD, appropriate services and prescribing, and medical homes (Nolan, Walker, Hanson, & Friedman). Across service types, innovative delivery models, such as family navigation, can empower families in lower-income settings advocate and receive for optimal care (Broder-Fingert et al., 2018; Parellada et al., 2013).

Our data indicate that ASD severity was associated with the amount of service types used, as children in the higher ASD-severity group received more types of services. This aligns with the hypothesis that children with more severe presentations may be tried on more services as a way to broaden the chance of finding a successful intervention (Akins et al., 2014; Rubenstein et al., 2018). In each strata of severity, insurance status was only associated with receipt of community-based behavioral therapy. These results are difficult to interpret due to our cross-sectional design, since we cannot determine whether current or past service use has altered severity, nor do we know the insurance status the child had in the past. Children with more severe presentation may have greater medical necessity which increases ability to get behavioral therapy under private insurance systems (Douglas et al., 2017). More research is needed into the effect of state insurance mandates on service use at the individual level, aiming to see if these laws specifically helped children with a more severe presentation.

Our study was limited by the single time point of data collection, preventing examination of the association between insurance status and service use prior to the time of study enrollment. Also, minimal details about services were available, including the number of hours, mode of delivery, and whether the insurer covered the service. We hope to assess these questions in the future using administrative data. Reporting on service use could have been impacted by recall bias due to varying amount of time since a service was used and the respondents understanding of the questions. Both insurance status and service use were reported by the mother and were not validated with medical records. It is additionally possible that the child received all needed service in the school setting and community-based service was not necessary. Although our sample was community-based and multi-site, the SEED sample is of a higher socioeconomic status than the underlying population and is only a sample from six states-results may not be generalizable to other samples or other states. Sample size was not large enough sample to examine the impacts of changes in state insurance laws, mandates, and waivers. State level differences were adjusted for by using study site as a random intercept, but with a larger sample, site level effects could be assessed. Finally, these data were collected between 2012 and 2016, so service use may have been impacted by policy changes (i.e. implementation of the Affordable Care Act) and preferences and trends which we were unable to quantify.

Implications

This study found that many preschool age children with a past ASD diagnosis did not receive community-based services, especially behavioral therapy. Children on public insurance only were more likely to receive medication and less likely to receive behavioral therapy compared to children with any private insurance. Because receiving adequate service is important for young children with ASD to receive optimal outcomes, enacting policies like Medicaid HCBS waivers and increased funding to reduce waitlists may get more children their desired health. Promoting practices like medical homes and pediatrician education may improve care once a child is in the health care system. Implementing community- and evidence-based intervention outside of clinic setting can also close disparity related gaps. Ultimately, improving the availability of evidence-based services to children in all types of insurance programs may improve service use and lead to improved outcomes.

Supplementary Material

1

Table 4.

Prevalence and odds ratios for amount of community-based service types used comparing insurance status in children with a previous diagnosis of autism spectrum disorder in the Study to Explore Early Development, stratified by Autism Diagnostic Observation Schedule Severity score

ADOS severity>=7 ADOS severity <7
% ORA 95% CI % ORA 95% CI
Amount of service types used *(PR)
Public 1.73 REF 1.13 REF
Private 1.58 0.92 0.70 1.21 0.88 0.77 0.54 1.11
Both 2.14 1.24 0.92 1.68 0.99 0.88 0.57 1.35
Behavioral therapy
Public 12.1 REF 5.0 REF
Private 34.0 3.06 1.23 7.59 19.6 1.18 0.35 3.95
Both 21.1 1.97 0.69 5.61 25.5 4.88 1.23 19.33
Medication
Public 13.4 REF 10.9 REF
Private 9.7 0.40 0.16 1.02 7.4 0.46 0.12 1.71
Both 14.0 0.67 0.23 1.94 2.1 0.21 0.02 2.09

PR prevalence ratio

OR odds ratio

CI confidence interval

Specific therapies chosen based on adequate sample size and significant findings in non-stratified sample

*

Amount of service types used used log-Poisson regression to estimate prevalence ratios, all other estimates are odds ratios derived from logistic regression

Adjusted for income, number of children in home, maternal education (no college or college or greater), race (white or non-white), and ethnicity, child year of birth and site as a random intercept.

Medication includes: anti-depressants, atypical antipsychotics, seizures or mood stabilizers, non-stimulants for hyperactivity, stimulant medications for hyperactivity

N=32 missing covariate data and dropped from model (5.4% of ADOS score <7), 3.1% of ADOS score>=7)

Bold indicates statistical significance at an alpha=0.05 level

Highlights.

  • Nearly 40% of preschool age children with ASD in the Study to Explore Early Development received no community-based services

  • Children on public insurance may be less likely to receive behavior therapy compared to other insurance types

  • Children on public insurance may be more likely to receive psychotropic medication compared to other insurance types.

Acknowledgements

The investigators acknowledge the contributions made to this study by project staff and enrolled families. The Bureau of Health Statistics and Research – PA Department of Health Harrisburg, PA, supplied a portion of these data. The PA Department of Health specifically disclaims responsibility for any analysis interpretations or conclusions. This publication was supported by six cooperative agreements from the Centers for Disease Control and Prevention (CDC): Cooperative Agreement Number U10DD000180, Colorado Department of Public Health; Cooperative Agreement Number U10DD000181, Kaiser Foundation Research Institute (CA); Cooperative Agreement Number U10DD000182, University of Pennsylvania; Cooperative Agreement Number U10DD000183, Johns Hopkins University; Cooperative Agreement Number U10DD000184, University of North Carolina at Chapel Hill; and Cooperative Agreement Number U10DD000498, Michigan State University. Eric Rubenstein was additionally supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number T32HD007489 and U54 HD090256. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC or NIH. The investigators have no conflicts of interest to report.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  1. Akins RS, Krakowiak P, Angkustsiri K, Hertz-Picciotto I, & Hansen RL (2014). Utilization patterns of conventional and complementary/alternative treatments in children with autism spectrum disorders and developmental disabilities in a population-based study. Journal of Developmental and Behavioral Pediatrics, 35(1), 1–10. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24399100. doi: 10.1097/DBP.0000000000000013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baio J, Wiggins LD, Christensen DL, Maenner MJ, Daniels J, Warren Z, … Dowling NF. (2018). Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014. Morbidity and Mortality Weekly Report. Surveillance Summaries, 67(6), 1–23. Retrieved from 10.15585/mmwr.ss6706a1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baribeau DA, &Anagnostou E (2014). An update on medication management of behavioral disorders in autism. Curr Psychiatry Rep, 16(3), 437 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24488702. doi: 10.1007/s11920-014-0437-0 [DOI] [PubMed] [Google Scholar]
  4. Barrett B, Mosweu I, Jones CR, Charman T, Baird G, Simonoff E, … Byford S (2015). Comparing service use and costs among adolescents with autism spectrum disorders, special needs and typical development. Autism, 19(5), 562–569. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24913778. doi: 10.1177/1362361314536626 [DOI] [PubMed] [Google Scholar]
  5. Barry CL, Epstein AJ, Marcus SC, Kennedy-Hendricks A, Candon MK, Xie M, & Mandell DS (2017). Effects Of State Insurance Mandates On Health Care Use And Spending For Autism Spectrum Disorder. Health Affairs, 36(10), 1754–1761. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/28971920. doi: 10.1377/hlthaff.2017.0515 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Benevides TW, Carretta HJ, Ivey CK, & Lane SJ (2017). Therapy access among children with autism spectrum disorder, cerebral palsy, and attention-deficit-hyperactivity disorder: a population-based study. Developmental Medicine and Child Neurology, 59(12), 1291–1298. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/28940224. doi: 10.1111/dmcn.13560 [DOI] [PubMed] [Google Scholar]
  7. Bohlander AJ, Orlich F, & Varley CK (2012). Social skills training for children with autism. Pediatric Clinics of North America, 59(1), 165–174, xii Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22284800. doi: 10.1016/j.pcl.2011.10.001 [DOI] [PubMed] [Google Scholar]
  8. Broder-Fingert S, Qin S, Goupil J, Rosenberg J, Augustyn M, Blum N, … Feinberg E (2018). A mixed-methods process evaluation of Family Navigation implementation for autism spectrum disorder. Autism, 1362361318808460 Retrieved from 10.1177/1362361318808460. doi: 10.1177/1362361318808460 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Broder-Fingert S, Shui A, Pulcini CD, Kurowski D, & Perrin JM (2013). Racial and ethnic differences in subspecialty service use by children with autism. Pediatrics, 132(1), 94–100. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23776121http://pediatrics.aappublications.Org/content/pediatrics/132/1/94.full.pdf. doi: 10.1542/peds.2012-3886 [DOI] [PubMed] [Google Scholar]
  10. Candon MK, Barry CL, Marcus SC, Epstein AJ, Kennedy-Hendricks A, Xie M, & Mandell DS (2018). Insurance Mandates and Out-of-Pocket Spending for Children With Autism Spectrum Disorder. Pediatrics. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/30541827. doi: 10.1542/peds.2018-0654 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Chou CH, Tulolo A, Raver EW, Hsu CH, & Young G (2013). Effect of race and health insurance on health disparities: results from the National Health Interview Survey 2010. Journal of Health Care for the Poor and Underserved, 24(3), 1353–1363. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23974404. doi: 10.1353/hpu.2013.0131 [DOI] [PubMed] [Google Scholar]
  12. Cidav Z, Marcus SC, & Mandell DS (2014). Home- and community-based waivers for children with autism: effects on service use and costs. Intellect Dev Disabil, 52(4), 239–248. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25061768. doi: 10.1352/1934-9556-52.4.239 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dawson G, & Burner K (2011). Behavioral interventions in children and adolescents with autism spectrum disorder: a review of recent findings. Current Opinion in Pediatrics, 23(6), 616–620. Retrieved from http://www.ncbi.nlm.nih.qov/pubmed/22037220. doi: 10.1097/MOP.0b013e32834cf082 [DOI] [PubMed] [Google Scholar]
  14. Douglas MD, Benevides TW, & Carretta H (2017). Analyzing State Autism Private Insurance Mandates for Allied Health Services: A Pilot Study. OTJR (Thorofare N J), 37(4), 218–226. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/28874097. doi: 10.1177/1539449217730355 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Harrington JW, & Allen K (2014). The Clinician’s Guide to Autism. Pediatrics in Review, 35(2), 62 Retrieved from http://pedsinreview.aappublications.org/content/35/2/62.abstract. [DOI] [PubMed] [Google Scholar]
  16. Hebert ML, Kehayia E, Prelock P, Wood-Dauphinee S, & Snider L (2014). Does occupational therapy play a role for communication in children with autism spectrum disorders? International Journal of Speech-Language Pathology, 16(6), 594–602. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24460071. doi: 10.3109/17549507.2013.876665 [DOI] [PubMed] [Google Scholar]
  17. Herlihy L, Knoch K, Vibert B, & Fein D (2015). Parents’ first concerns about toddlers with autism spectrum disorder: effect of sibling status. Autism, 19(1), 20–28. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24216070. doi: 10.1177/1362361313509731 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Horlin C, Falkmer M, Parsons R, Albrecht MA, & Falkmer T (2014). The cost of autism spectrum disorders. PloS One, 9(9), e106552 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25191755. doi: 10.1371/journal.pone.0106552 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Houghton R, Ong RC, & Bolognani F (2017). Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States. Autism Res, 10(12), 2037–2047. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/28963809. doi: 10.1002/aur.1848 [DOI] [PubMed] [Google Scholar]
  20. Individuals with Disabilities Education Improvement Act of 2004, 108-446 § 1400 (2004).
  21. Jackel C, Shults J, Wiley S, Meinzen-Derr J, Augustyn M, & Blum N (2017). Factors Associated with Developmental Behavioral Pediatricians Prescribing Psychotropic Medication to Children with Autism Spectrum Disorder: A Study of Three DBPNet Sites. Journal of Developmental and Behavioral Pediatrics, 38(8), 584–592. doi: 10.1097/dbp.0000000000000488 [DOI] [PubMed] [Google Scholar]
  22. Kasari C (2015). Update on behavioral interventions for autism and developmental disabilities. Current Opinion in Neurology, 28(2), 124–129. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25695136. doi: 10.1097/WCO.0000000000000185 [DOI] [PubMed] [Google Scholar]
  23. Koegel LK, Koegel RL, Ashbaugh K, & Bradshaw J (2014). The importance of early identification and intervention for children with or at risk for autism spectrum disorders. International Journal of Speech-Language Pathology, 16(1), 50–56. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24328352. doi: 10.3109/17549507.2013.861511 [DOI] [PubMed] [Google Scholar]
  24. Landa RJ, & Kalb LG (2012). Long-term outcomes of toddlers with autism spectrum disorders exposed to short-term intervention. Pediatrics, 130 Suppl 2, S186–190. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23118250. doi: 10.1542/peds.2012-0900Q [DOI] [PubMed] [Google Scholar]
  25. Leigh JP, Grosse SD, Cassady D, Melnikow J, & Hertz-Picciotto I (2016). Spending by California’s Department of Developmental Services for Persons with Autism across Demographic and Expenditure Categories. PloS One, 11(3), e0151970 Retrieved from http://www.ncbi.nlm.nih.qov/pubmed/27015098. doi: 10.1371/journal.pone.0151970 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Leslie DL, Iskandarani K, Dick AW, Mandell DS, Yu H, Velott D, … Stein BD (2017). The Effects of Medicaid Home and Community-based Services Waivers on Unmet Needs Among Children With Autism Spectrum Disorder. Medical Care, 55(1), 57–63. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27547947. doi: 10.1097/MLR.0000000000000621 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Levy SE, & Hyman SL (2015). Complementary and alternative medicine treatments for children with autism spectrum disorders. Child and Adolescent Psychiatric Clinics of North America, 24(1), 117–143. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25455579. doi: 10.1016/j.chc.2014.09.004 [DOI] [PubMed] [Google Scholar]
  28. Lindly OJ, Zuckerman KE, & Kuhlthau KA (2018). Healthcare access and services use among US children with autism spectrum disorder. Autism, 1362361318815237 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/30497274. doi: 10.1177/1362361318815237 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Locke J, Kang-Yi CD, Pellecchia M, Marcus S, Hadley T, & Mandell DS (2017). Ethnic Disparities in School-Based Behavioral Health Service Use for Children With Psychiatric Disorders. Journal of School Health, 87(1), 47–54. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27917490. doi: 10.1111/josh.12469 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Lord C, Elsabbagh M, Baird G, & Veenstra-Vanderweele J (2018). Autism spectrum disorder. Lancet, 392(10146), 508–520. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/30078460. doi: 10.1016/S0140-6736(18)31129-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Lord C, Risi S, Lambrecht L, Cook EH Jr., Leventhal BL, DiLavore PC, … Rutter M (2000). The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. Journal of Autism and Developmental Disorders, 30(3), 205–223. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11055457. doi: 10.1023/A:1005592401947 [DOI] [PubMed] [Google Scholar]
  32. Miller NA, Merryman MB, Eskow KG, & Chasson GS (2016). State Design and Use of Medicaid 1915(c) Waivers and Related Benefits to Provide Services to Children and Youth With Autism Spectrum Disorder. Am J Intellect Dev Disabil, 121(4), 295–311. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27351698. doi: 10.1352/1944-7558-121.4.295 [DOI] [PubMed] [Google Scholar]
  33. Mire SS, Raff NS, Brewton CM, & Goin-Kochel RP (2015). Age-related trends in treatment use for children with autism spectrum disorder. Research in Autism Spectrum Disorders, 15-16, 29–41. doi: 10.1016/j.rasd.2015.03.001 [DOI] [Google Scholar]
  34. Nolan R, Walker T, Hanson JL, & Friedman S (2016). Developmental Behavioral Pediatrician Support of the Medical Home for Children with Autism Spectrum Disorders. Journal of developmental & behavioral pediatrics, 37(9), 687–693. doi: 10.1097/DBP.0000000000000348 [DOI] [PubMed] [Google Scholar]
  35. O’Hare A, & Bremner L (2016). Management of developmental speech and language disorders: Part 1. Archives of Disease in Childhood, 101(3), 272–277. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26208514. doi: 10.1136/archdischild-2014-307394 [DOI] [PubMed] [Google Scholar]
  36. Parellada M, Boada L, Moreno C, Llorente C, Romo J, Muela C, & Arango C (2013). Specialty Care Programme for autism spectrum disorders in an urban population: A case-management model for health care delivery in an ASD population. European Psychiatry, 28(2), 102–109. Retrieved from http://www.sciencedirect.com/science/article/pii/S092493381100109X. doi: 10.1016/i.eurpsy.2011.06.004 [DOI] [PubMed] [Google Scholar]
  37. Payakachat N, Tilford JM, & Kuhlthau KA (2018). Parent-Reported Use of Interventions by Toddlers and Preschoolers With Autism Spectrum Disorder. Psychiatric Services, 69(2), 186–194. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/29032701. doi: 10.1176/appi.ps.201600524 [DOI] [PubMed] [Google Scholar]
  38. Reichow B, Hume K, Barton EE, & Boyd BA (2018). Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD). Cochrane Database Syst Rev, 5, CD009260 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/29742275. doi: 10.1002/14651858.CD009260.pub3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Rubenstein E, Schieve L, Bradley C, DiGuiseppi C, Moody E, Thomas K, & Daniels J (2018). The prevalence of gluten free diet use among preschool children with autism spectrum disorder. Autism Res, 11(1), 185–193. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/29155492. doi: 10.1002/aur.1896 [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Rutter M, Bailey A, & Lord C (2003). SCQ: Social Communication Questionnaire. In. Los Angeles, CA: Western Psychological Services. [Google Scholar]
  41. Schendel DE, Diguiseppi C, Croen LA, Fallin MD, Reed PL, Schieve LA, … Yeargin-Allsopp M (2012). The Study to Explore Early Development (SEED): a multisite epidemiologic study of autism by the Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE) network. Journal of Autism and Developmental Disorders, 42(10), 2121–2140. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22350336. doi: 10.1007/s10803-012-1461-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Semansky RM, Xie M, Lawer LJ, & Mandell DS (2013). How states use Medicaid to fund community-based services to children with autism spectrum disorders. Psychiatric Services, 64(10), 1051–1055. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24081405. doi: 10.1176/appi.ps.201200390 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Stahmer AC, Suhrheinrich J, & Mandell DS (2016). The importance of characterizing intervention for individuals with autism. Autism, 20(4), 386–387. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27099383. doi: 10.1177/1362361316637503 [DOI] [PubMed] [Google Scholar]
  44. Thomas KC, Parish SL, & Williams CS (2014). Healthcare expenditures for autism during times of school transition: some vulnerable families fall behind. Matern Child Health J, 18(8), 1936–1944. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24553795. doi: 10.1007/s10995-014-1439-6 [DOI] [PubMed] [Google Scholar]
  45. Velott DL, Agbese E, Mandell D, Stein BD, Dick AW, Yu H, & Leslie DL (2016). Medicaid 1915(c) Home- and Community-Based Services waivers for children with autism spectrum disorder. Autism, 20(4), 473–482. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26088059. doi: 10.1177/1362361315590806 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Vivanti G, Kasari C, Green J, Mandell D, Maye M, & Hudry K (2018). Implementing and evaluating early intervention for children with autism: Where are the gaps and what should we do? Autism Research, 11(1), 16–23. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/29206358. doi: 10.1002/aur.1900 [DOI] [PubMed] [Google Scholar]
  47. Vohra R, Madhavan S, & Sambamoorthi U (2017). Comorbidity prevalence, healthcare utilization, and expenditures of Medicaid enrolled adults with autism spectrum disorders. Autism, 21(8), 995–1009. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/27875247. doi: 10.1177/1362361316665222 [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Wang L, Mandell DS, Lawer L, Cidav Z, & Leslie DL (2013). Healthcare service use and costs for autism spectrum disorder: a comparison between medicaid and private insurance. Journal of Autism and Developmental Disorders, 43(5), 1057–1064. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22965299. doi: 10.1007/s10803-012-1649-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Wiggins LD, Bakeman R, Adamson LB, & Robins DL (2007). The utility of the Social Communication Questionnaire in screening for autism in children referred for early intervention. Focus Autism Other Dev Disabl, 22(1), 33–38. Retrieved from http://foa.sagepub.com/content/22/1/33.abstract. doi: 10.1177/10883576070220010401 [DOI] [Google Scholar]
  50. Wiggins LD, Levy SE, Daniels J, Schieve L, Croen LA, DiGuiseppi C, … Schendel D (2015). Autism spectrum disorder symptoms among children enrolled in the Study to Explore Early Development (SEED). Journal of Autism and Developmental Disorders, 45(10), 3183–3194. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26048040. doi: 10.1007/s10803-015-2476-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Zablotsky B, Pringle BA, Colpe LJ, Kogan MD, Rice C, & Blumberg SJ (2015). Service and treatment use among children diagnosed with autism spectrum disorders. Journal of Developmental and Behavioral Pediatrics, 36(2), 98–105. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25650952. doi: 10.1097/DBP.0000000000000127 [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Zhang W, & Baranek G (2016). The Impact of Insurance Coverage Types on Access to and Utilization of Health Services for U.S. Children With Autism. Psychiatric Services, 67(8), 908–911. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27079986. doi: 10.1176/appi.ps.201500206 [DOI] [PubMed] [Google Scholar]
  53. Zwaigenbaum L, Bauman ML, Choueiri R, Kasari C, Carter A, Granpeesheh D, … Natowicz MR (2015). Early Intervention for Children With Autism Spectrum Disorder Under 3 Years of Age: Recommendations for Practice and Research. Pediatrics, 136(Supplement 1), S60 Retrieved from http://pediatrics.aappublications.org/content/136/Supplement_1/S60.abstract. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

RESOURCES